Effect of nusinersen on pulmonary function in children with spinal muscular atrophy in the plateau region: A pilot study
Background: The drug nusinersen is applied to improve motor function in patients with spinal muscle atrophy (SMA). However, research on the effects of this treatment on lung function is lacking. Aim: To investigate the effect of nusinersen on lung function in children with SMA in the Plateau. Method...
Saved in:
Main Authors: | Jicai Zhu, Xiaofang Chen, Haoke Sang, Minming Ma, Chunhui Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-01-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024174191 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and Efficacy of Nusinersen Focusing on Renal and Hematological Parameters in Spinal Muscular Atrophy
by: Hüseyin Bahadır Şenol, et al.
Published: (2025-01-01) -
Reviews of spinal muscular atrophy in Taiwan
by: Yung-Hsiu Lu, et al.
Published: (2024-12-01) -
Maximal mouth opening in infants and toddlers with spinal muscular atrophy: a prospective controlled study
by: Jana Zang, et al.
Published: (2025-01-01) -
Rare coexistence of spinal muscular atrophy with membranous nephropathy – A clinical conundrum with management dilemma
by: Gerry G. Mathew, et al.
Published: (2024-12-01) -
Quality of life in patients with spinal muscular atrophy in Brazil: patient self-assessment and carer perception
by: Maíra Coelho, et al.
Published: (2025-01-01)